KV Pharma files for Chapter 11 bankruptcy protection and shares ceas...

08/06/12

KV Pharma files for Chapter 11 bankruptcy protection and shares cease trading ...
Washington Post
NEW YORK — K-V Pharmaceutical Co. has filed filing for Chapter 11 bankruptcy protection as it deals with weak sales, a payment related to its costly preterm birth drug Makena, and sanctions related to past manufacturing problems. The St. Louis company ...